Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(23):1992-1993; doi:10.1093/jnci/91.23.1992
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Volkers, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Volkers, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 23, 1992-1993, December 1, 1999
© 1999 Oxford University Press

NEWS

Do Autoimmune Diseases Raise The Risk of Cancer?

Nancy Volkers

Is there a link buried in the immune system between autoimmune disease, when the body mistakenly turns on itself, and cancer, when the body should attack itself, but does not?

Although several studies have shown that a history of autoimmune disease increases the risk of cancer, the results are complicated by the fact that some treatments for common conditions, such as lupus and rheumatoid arthritis, also may increase this risk.

A registry linkage study published in 1998 found that lupus patients — who are mostly women — have a twofold risk of cancer compared with people who do not have lupus. A 1997 study in Shanghai, China, found a 2.4-fold . . . [Full Text of this Article]

GSTs — a Link?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
R. E. Curtis, C. Metayer, J. D. Rizzo, G. Socie, K. A. Sobocinski, M. E. D. Flowers, W. D. Travis, L. B. Travis, M. M. Horowitz, and H. J. Deeg
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
Blood, May 15, 2005; 105(10): 3802 - 3811.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Sun, G. Matthias, M. J. Mihatsch, K. Georgopoulos, and P. Matthias
Lack of the Transcriptional Coactivator OBF-1 Prevents the Development of Systemic Lupus Erythematosus-Like Phenotypes in Aiolos Mutant Mice
J. Immunol., February 15, 2003; 170(4): 1699 - 1706.
[Abstract] [Full Text] [PDF]